BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 31
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (8982)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.
Item 
Count 
PDF592
WORD259
HTML6168
Tables (1-3)135
 Sum=7154
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1045
Download783
 Sum=1828
Aug 21, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Ghiorzo P. Genetic predisposition to pancreatic cancer. World J Gastroenterol 2014; 20(31): 10778-10789 [PMID: 25152581 DOI: 10.3748/wjg.v20.i31.10778]
URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10778.htm
Number Citing Articles
1
Bryce A. Seifert, Julianne M. O'Daniel, Krunal Amin, Daniel S. Marchuk, Nirali M. Patel, Joel S. Parker, Alan P. Hoyle, Lisle E. Mose, Andrew Marron, Michele C. Hayward, Christopher Bizon, Kirk C. Wilhelmsen, James P. Evans, H. Shelton Earp, Norman E. Sharpless, D. Neil Hayes, Jonathan S. Berg. Germline Analysis from Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings. Clinical Cancer Research 2016; 22(16): 4087 doi: 10.1158/1078-0432.CCR-16-0015
2
Cade Bennett, Mike Suguitan, John Abad, Akhil Chawla. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines. Pancreatology 2022; 22(6): 719 doi: 10.1016/j.pan.2022.05.005
3
Alexandra R Lewis, Juan W Valle, Mairead G McNamara. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?. World Journal of Gastroenterology 2016; 22(32): 7175-7185 doi: 10.3748/wjg.v22.i32.7175
4
Eileen E. Reynolds, Chyke A. Doubeni, Mandeep S. Sawhney, Zahir Kanjee. Should This Patient Be Screened for Pancreatic Cancer?. Annals of Internal Medicine 2020; 173(11): 914 doi: 10.7326/M20-6384
5
Kinyas Kartal, Zoe Guan, Rong Tang, Molly Griffin, Yan Wang, Danielle Braun, Alison P. Klein, Kevin S. Hughes. Familial pancreatic cancer: who should be considered for genetic testing?. Irish Journal of Medical Science (1971 -) 2022; 191(2): 641 doi: 10.1007/s11845-021-02572-9
6
Wei Zhan, Celeste A. Shelton, Phil J. Greer, Randall E. Brand, David C. Whitcomb. Germline Variants and Risk for Pancreatic Cancer. Pancreas 2018; 47(8): 924 doi: 10.1097/MPA.0000000000001136
7
A. J. Muñoz, M. de Toro, L. Ortega, C. López, A. Gutiérrez, D. S. Juliao, M. Arregui, N. Lobato, I. Echavarría, I. Márquez-Rodas, M. Martín. Venous thromboembolism incidence in cancer patients with germline BRCA mutations. Clinical and Translational Oncology 2022; 24(1): 154 doi: 10.1007/s12094-021-02678-7
8
Farhadul Islam. Current Cancer Biomarkers. 2023; : 81 doi: 10.2174/9789815079364123010008
9
Tanya Dwarte, Skye McKay, Amber Johns, Katherine Tucker, Allan D. Spigelman, David Williams, Alina Stoita. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program. Hereditary Cancer in Clinical Practice 2019; 17(1) doi: 10.1186/s13053-019-0129-1
10
Arivajiagane Arundhathi, Wen-Han Chuang, Jen-Kun Chen, Shin-E Wang, Yi-Ming Shyr, Jiun-Yu Chen, Wei-Neng Liao, Hsin-Wei Chen, Yi-Min Teng, Chiao-Chih Pai, Chih-Hong Wang. Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis. Oncotarget 2016; 7(34): 55437 doi: 10.18632/oncotarget.10583
11
Gina Gheorghe, Camelia Cristina Diaconu, Vlad Ionescu, Gabriel Constantinescu, Nicolae Bacalbasa, Simona Bungau, Mihnea-Alexandru Gaman, Madalina Stan-Ilie. Risk Factors for Pancreatic Cancer: Emerging Role of Viral Hepatitis. Journal of Personalized Medicine 2022; 12(1): 83 doi: 10.3390/jpm12010083
12
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh, Anke Reinacher-Schick, Giampaolo Tortora, Hana Algül, Eileen M. O’Reilly, David McGuinness, Karen Y. Cui, Katia Schlienger, Gershon Y. Locker, Hedy L. Kindler. Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer . New England Journal of Medicine 2019; 381(4): 317 doi: 10.1056/NEJMoa1903387
13
C. Langner. Hereditäres Magen- und Pankreaskarzinom. Der Pathologe 2017; 38(3): 164 doi: 10.1007/s00292-017-0297-6
14
Nuria Garcia-Carbonero, Weiyao Li, Marticela Cabeza-Morales, Javier Martinez-Useros, Jesus Garcia-Foncillas. New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review. International Journal of Molecular Sciences 2018; 19(9): 2468 doi: 10.3390/ijms19092468
15
Mark Steven Miller, Peter Allen, Teresa A. Brentnall, Michael Goggins, Ralph H. Hruban, Gloria M. Petersen, Chinthalapally V. Rao, David C. Whitcomb, Randall E. Brand, Suresh T. Chari, Alison P. Klein, David M. Lubman, Andrew D. Rhim, Diane M. Simeone, Brian M. Wolpin, Asad Umar, Sudhir Srivastava, Vernon E. Steele, Jo Ann S. Rinaudo. Pancreatic Cancer Chemoprevention Translational Workshop. Pancreas 2016; 45(8): 1080 doi: 10.1097/MPA.0000000000000705
16
Shria Kumar, David C. Metz, David E. Kaplan, David S. Goldberg. The association of Helicobacter pylori with pancreatic cancer . GastroHep 2020; 2(4): 157 doi: 10.1002/ygh2.398
17
Wenzel M. Hackeng, Ralph H. Hruban, G. Johan A. Offerhaus, Lodewijk A. A. Brosens. Surgical and molecular pathology of pancreatic neoplasms. Diagnostic Pathology 2016; 11(1) doi: 10.1186/s13000-016-0497-z
18
Yousef M. Hawsawi, Nouf S. Al‐Numair, Turki M. Sobahy, Areej M. Al‐Ajmi, Raneem M. Al‐Harbi, Mohammed A. Baghdadi, Atif A. Oyouni, Osama M. Alamer. The role of BRCA1/2 in hereditary and familial breast and ovarian cancers. Molecular Genetics & Genomic Medicine 2019; 7(9) doi: 10.1002/mgg3.879
19
Timothy J. Brown, Kim A. Reiss. PARP Inhibitors in Pancreatic Cancer. The Cancer Journal 2021; 27(6): 465 doi: 10.1097/PPO.0000000000000554
20
Uma L. Sreedhar, Steve V. DeSouza, Brittany Park, Maxim S. Petrov. A Systematic Review of Intra-pancreatic Fat Deposition and Pancreatic Carcinogenesis. Journal of Gastrointestinal Surgery 2020; 24(11): 2560 doi: 10.1007/s11605-019-04417-4
21
Valentina Giansante, Gianmarco Stati, Silvia Sancilio, Emanuela Guerra, Saverio Alberti, Roberta Di Pietro. The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(16): 12633 doi: 10.3390/ijms241612633
22
Sarah Schott, Rongxi Yang, Sarah Stöcker, Federico Canzian, Nathalia Giese, Peter Bugert, Frank Bergmann, Oliver Strobel, Thilo Hackert, Christof Sohn, Barbara Burwinkel. HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study. Oncotarget 2017; 8(40): 67614 doi: 10.18632/oncotarget.18757
23
Michelle F. Jacobs, Elena M. Stoffel. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). Familial Cancer 2024;  doi: 10.1007/s10689-024-00372-5
24
Sancy A. Leachman, Olivia M. Lucero, Jone E. Sampson, Pamela Cassidy, William Bruno, Paola Queirolo, Paola Ghiorzo. Identification, genetic testing, and management of hereditary melanoma. Cancer and Metastasis Reviews 2017; 36(1): 77 doi: 10.1007/s10555-017-9661-5
25
Inès Debbabi, Sophie Vacher, Cindy Neuzillet, Jérome Cros, Françoise Revillon, Ambre Petitalot, Anthony Turpin, Samantha Antonio, Elodie Girard, Célia Dupain, Maud Kamal, Pascal Hammel, Ivan Bièche, Julien Masliah-Planchon, Sandrine M. Caputo. Identification of a large intra-exonic deletion in BRCA2 exon 18 in a pancreatic ductal adenocarcinoma. Therapeutic Advances in Medical Oncology 2023; 15: 175883592211461 doi: 10.1177/17588359221146132
26
Ayoola O Ogunleye, Rama Krishna Nimmakayala, Surinder K Batra, Moorthy P Ponnusamy. Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression. Stem Cells 2023; 41(5): 417 doi: 10.1093/stmcls/sxad017
27
Rachel Michaelson-Cohen, Rachel Beeri, Eliahu Golomb, Ephrat Levy-Lahad. Molecular Pathology in Clinical Practice. 2016; : 315 doi: 10.1007/978-3-319-19674-9_22
28
Jone E. Sampson, Kelly Jo Hamman. A current picture of genetic counseling for familial pancreatic cancer. Expert Review of Quality of Life in Cancer Care 2016; 1(6): 425 doi: 10.1080/23809000.2016.1255552
29
Xin Hu, Zhiyi Xie, Xin Zan, Lu Ma, Hao Li, Chao You, Yan Jiang. Role of Apolipoprotein E Genotypes in Aneurysmal Subarachnoid Hemorrhage: Susceptibility, Complications, and Prognosis. World Neurosurgery 2018; 118: e666 doi: 10.1016/j.wneu.2018.07.019
30
Mark B. Ulanja, Alastair E. Moody, Bryce D. Beutler, Daniel Antwi-Amoabeng, Ganiyu A. Rahman, Olatunji B. Alese. Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival. Oncotarget 2022; 13(1): 828 doi: 10.18632/oncotarget.28242
31
William Bruno, Virginia Andreotti, Alessandra Bisio, Lorenza Pastorino, Giuseppe Fornarini, Stefania Sciallero, Giovanna Bianchi-Scarrà, Alberto Inga, Paola Ghiorzo, Alvaro Galli. Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development. PLOS ONE 2017; 12(12): e0189123 doi: 10.1371/journal.pone.0189123
32
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Philippe Bourget, Jérôme Cros, Anne Couvelard, Alain Sauvanet, Marie-Pierre Vullierme, Christophe Tournigand, Pascal Hammel. State of the art and future directions of pancreatic ductal adenocarcinoma therapy. Pharmacology & Therapeutics 2015; 155: 80 doi: 10.1016/j.pharmthera.2015.08.006
33
Eleonora Lai, Pina Ziranu, Dario Spanu, Marco Dubois, Andrea Pretta, Simona Tolu, Silvia Camera, Nicole Liscia, Stefano Mariani, Mara Persano, Marco Migliari, Clelia Donisi, Laura Demurtas, Valeria Pusceddu, Marco Puzzoni, Mario Scartozzi. BRCA-mutant pancreatic ductal adenocarcinoma. British Journal of Cancer 2021; 125(10): 1321 doi: 10.1038/s41416-021-01469-9
34
Diana Behrens, Ulrike Pfohl, Theresia Conrad, Michael Becker, Bernadette Brzezicha, Britta Büttner, Silvia Wagner, Cora Hallas, Rita Lawlor, Vladimir Khazak, Michael Linnebacher, Thomas Wartmann, Iduna Fichtner, Jens Hoffmann, Mathias Dahlmann, Wolfgang Walther. Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing. Cancers 2023; 15(24): 5753 doi: 10.3390/cancers15245753
35
Benjamin Musher, Huili Zhu. Pancreatic Cancer. 2023; : 57 doi: 10.1007/978-3-031-38623-7_4
36
Humaira Sarfraz, Aditi Saha, Khushali Jhaveri, Dae Won Kim. Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma. Current Oncology 2023; 30(6): 5322 doi: 10.3390/curroncol30060404
37
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song. Gastrointestinal Cancer. 2023; : 329 doi: 10.1007/978-981-99-0815-8_48
38
Lisa Lellouche, Lola-Jade Palmieri, Solène Dermine, Catherine Brezault, Stanislas Chaussade, Romain Coriat. Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives. Therapeutic Advances in Medical Oncology 2021; 13: 175883592110185 doi: 10.1177/17588359211018539
39
Mei Zhan, Hanrui Zheng, Yu Yang, Zhiyao He, Ting Xu, Qiu Li. <p>Cost-Effectiveness Analysis of Maintenance Olaparib in Patients with Metastatic Pancreatic Cancer and a Germline BRCA1/2 Mutation Based on the POLO Trial</p>. Cancer Management and Research 2020; : 12919 doi: 10.2147/CMAR.S283169
40
Daniele Fanale, Giorgio Madonia, Antonio Galvano, Marc Peeters, Albert J. ten Tije, Juan Lucio Iovanna, Antonio Russo. Practical Medical Oncology Textbook. UNIPA Springer Series 2021; : 645 doi: 10.1007/978-3-030-56051-5_40
41
Wen‐Ling Kuo, Po‐Han Lin, Meng‐Ting Peng, Chia‐Hui Chu, Chia‐Wei Cho. Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single‐country, multi‐center, patient‐reported outcome study. Journal of Genetic Counseling 2023; 32(4): 788 doi: 10.1002/jgc4.1688
42
M. Borecka, P. Zemankova, M. Vocka, P. Soucek, J. Soukupova, P. Kleiblova, J. Sevcik, Z. Kleibl, M. Janatova. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. Cancer Genetics 2016; 209(5): 199 doi: 10.1016/j.cancergen.2016.03.003
43
Baohuan Li, Chuanzhen Zhang, Jingjing Wang, Meijuan Zhang, Changhong Liu, Ziping Chen. Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients. Molecular Genetics & Genomic Medicine 2020; 8(6) doi: 10.1002/mgg3.1226
44
Shria Kumar, Monica Saumoy, Aaron Oh, Yecheskel Schneider, Randall E. Brand, Amitabh Chak, Gregory G. Ginsberg, Michael L. Kochman, Marcia Irene Canto, Michael Gilbert Goggins, Chin Hur, Fay Kastrinos, Bryson W. Katona, Anil K. Rustgi. Threshold Analysis of the Cost-effectiveness of Endoscopic Ultrasound in Patients at High Risk for Pancreatic Ductal Adenocarcinoma. Pancreas 2021; 50(6): 807 doi: 10.1097/MPA.0000000000001835
45
Shiao Li Oei, Friedemann Schad. Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy?. Cancers 2023; 15(4): 1116 doi: 10.3390/cancers15041116
46
Carmelo Laface, Riccardo Memeo. Clinical Updates for Gastrointestinal Malignancies. Journal of Personalized Medicine 2023; 13(9): 1424 doi: 10.3390/jpm13091424
47
Gina Gheorghe, Simona Bungau, Madalina Ilie, Tapan Behl, Cosmin Mihai Vesa, Ciprian Brisc, Nicolae Bacalbasa, Vladiana Turi, Raluca Simona Costache, Camelia Cristina Diaconu. Early Diagnosis of Pancreatic Cancer: The Key for Survival. Diagnostics 2020; 10(11): 869 doi: 10.3390/diagnostics10110869
48
Sriram Anbil, Kim A. Reiss. Targeting BRCA and PALB2 in Pancreatic Cancer. Current Treatment Options in Oncology 2024; 25(3): 346 doi: 10.1007/s11864-023-01174-0
49
Deqiang Wang, Ruting Guan, Qing Tao, Sisi Liu, Man Yu, Xiaoqin Li. A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report. BMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-020-00850-6
50
Atul Batra, Patricia A. Tang, Winson Y. Cheung. Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy. American Journal of Clinical Oncology 2021; 44(10): 519 doi: 10.1097/COC.0000000000000856
51
Leticia Estefania Campoverde, Felipe Batalini, Yarab Bulushi, Andrea Bullock. Response inBRCA1mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX. BMJ Case Reports 2022; 15(4): e249370 doi: 10.1136/bcr-2022-249370
52
Daniele Campa, Manuela Pastore, Manuel Gentiluomo, Renata Talar-Wojnarowska, Juozas Kupcinskas, Ewa Malecka-Panas, John P. Neoptolemos, Willem Niesen, Pavel Vodicka, Gianfranco Delle Fave, H. Bas Bueno-de-Mesquita, Maria Gazouli, Paola Pacetti, Milena Di Leo, Hidemi Ito, Harald Klüter, Pavel Soucek, Vincenzo Corbo, Kenji Yamao, Satoyo Hosono, Rudolf Kaaks, Yogesh Vashist, Domenica Gioffreda, Oliver Strobel, Yasuhiro Shimizu, Frederike Dijk, Angelo Andriulli, Audrius Ivanauskas, Peter Bugert, Francesca Tavano, Ludmila Vodickova, Carlo Federico Zambon, Martin Lovecek, Stefano Landi, Timothy J. Key, Ugo Boggi, Raffaele Pezzilli, Krzysztof Jamroziak, Beatrice Mohelnikova-Duchonova, Andrea Mambrini, Franco Bambi, Olivier Busch, Valerio Pazienza, Roberto Valente, George E. Theodoropoulos, Thilo Hackert, Gabriele Capurso, Giulia Martina Cavestro, Claudio Pasquali, Daniela Basso, Cosimo Sperti, Keitaro Matsuo, Markus Büchler, Kay-Tee Khaw, Jakob Izbicki, Eithne Costello, Verena Katzke, Christoph Michalski, Anna Stepien, Cosmeri Rizzato, Federico Canzian. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Oncotarget 2016; 7(35): 57011 doi: 10.18632/oncotarget.10935
53
Nora B. Henrikson, Erin J. Aiello Bowles, Paula R. Blasi, Caitlin C. Morrison, Matt Nguyen, Venu G. Pillarisetty, Jennifer S. Lin. Screening for Pancreatic Cancer. JAMA 2019; 322(5): 445 doi: 10.1001/jama.2019.6190
54
Thao N. D. Pham, Mario A. Shields, Christina Spaulding, Daniel R. Principe, Bo Li, Patrick W. Underwood, Jose G. Trevino, David J. Bentrem, Hidayatullah G. Munshi. Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies. Cancers 2021; 13(3): 440 doi: 10.3390/cancers13030440
55
Caroline Goehringer, Christian Sutter, Matthias Kloor, Johannes Gebert, Emily P. Slater, Monika Keller, Irmgard Treiber, Petra Ganschow, Martina Kadmon, Ute Moog. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor. Familial Cancer 2017; 16(2): 303 doi: 10.1007/s10689-016-9952-y
56
Bruna Dalmasso, Lorenza Pastorino, Giulia Ciccarese, Virginia Andreotti, Federica Grillo, Luca Mastracci, Francesco Spagnolo, Alberto Ballestrero, Paola Queirolo, William Bruno, Paola Ghiorzo. CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients. Journal of the American Academy of Dermatology 2019; 80(5): 1263 doi: 10.1016/j.jaad.2018.07.060
57
Hedy L. Kindler, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall, Joon Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh, Anke Reinacher-Schick, Giampaolo Tortora, Hana Algül, Eileen M. O'Reilly, Sonal Bordia, David McGuinness, Karen Cui, Gershon Y. Locker, Talia Golan. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Journal of Clinical Oncology 2022; 40(34): 3929 doi: 10.1200/JCO.21.01604
58
Katie L. Hwang, Wolfram Goessling. Cancer and Zebrafish. Advances in Experimental Medicine and Biology 2016; 916: 391 doi: 10.1007/978-3-319-30654-4_17
59
Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini. Prognostic and predictive factors in pancreatic cancer. Oncotarget 2020; 11(10): 924 doi: 10.18632/oncotarget.27518
60
Bruna Dalmasso, Alberto Puccini, Fabio Catalano, Roberto Borea, Maria Laura Iaia, William Bruno, Giuseppe Fornarini, Stefania Sciallero, Sara Elena Rebuzzi, Paola Ghiorzo. Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients. International Journal of Molecular Sciences 2022; 23(9): 4709 doi: 10.3390/ijms23094709
61
Barbara Geerinckx, Laure-Anne Teuwen, Tiffany Foo, Timon Vandamme, Annabel Smith, Marc Peeters, Timothy Price. Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy. Expert Review of Anticancer Therapy 2023; 23(12): 1237 doi: 10.1080/14737140.2023.2270161
62
Jian-Xiong Hu, Cheng-Fei Zhao, Wen-Biao Chen, Qi-Cai Liu, Qu-Wen Li, Yan-Ya Lin, Feng Gao. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World Journal of Gastroenterology 2021; 27(27): 4298-4321 doi: 10.3748/wjg.v27.i27.4298
63
Gianluca Cassese, Ho-Seong Han, Yoo-Seok Yoon, Jun Suh Lee, Boram Lee, Antonio Cubisino, Fabrizio Panaro, Roberto Ivan Troisi. Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. World Journal of Gastrointestinal Oncology 2023; 15(6): 911-924 doi: 10.4251/wjgo.v15.i6.911
64
Xiaobo Peng, Ling Chen, Yuan Jiao, Yujie Wang, Zhibin Hao, Xianbao Zhan. Application of natural killer cells in pancreatic cancer (Review). Oncology Letters 2021; 22(3) doi: 10.3892/ol.2021.12908
65
Nozomi Okuno, Kazuo Hara. Endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling. Journal of Medical Ultrasonics 2024;  doi: 10.1007/s10396-023-01403-x
66
William Bruno, Giuseppe Fornarini, Paola Ghiorzo. Signs and genetics of rare cancer syndromes with gastroenterological features. World Journal of Gastroenterology 2015; 21(30): 8985-8993 doi: 10.3748/wjg.v21.i30.8985
67
Hanno Matthaei, Alexander Semaan, Ralph H. Hruban. The genetic classification of pancreatic neoplasia. Journal of Gastroenterology 2015; 50(5): 520 doi: 10.1007/s00535-015-1037-4
68
Yunzhen Qian, Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Shengming Deng, He Cheng, Kaizhou Jin, Quanxing Ni, Xianjun Yu, Chen Liu. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. Journal of Hematology & Oncology 2020; 13(1) doi: 10.1186/s13045-020-00958-3
69
Manuel Gentiluomo, Federico Canzian, Andrea Nicolini, Federica Gemignani, Stefano Landi, Daniele Campa. Germline genetic variability in pancreatic cancer risk and prognosis. Seminars in Cancer Biology 2022; 79: 105 doi: 10.1016/j.semcancer.2020.08.003
70
Anke Kröcher, Gunnar Folprecht, Robert Winzer, Mildred Sergon, Martin Bornhäuser, Jörg Kotzerke, Claudia Brogsitter. Successful Combination of Olaparib and <sup>225</sup>Ac-Dotatate in a Patient with Neuroendocrine Tumor G3 and BRCA Mutation. Case Reports in Oncology 2023; 16(1): 1166 doi: 10.1159/000533198
71
Aamir Ali Khan, Xinhui Liu, Xinlong Yan, Muhammad Tahir, Sakhawat Ali, Hua Huang. An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression. Cancer and Metastasis Reviews 2021; 40(1): 245 doi: 10.1007/s10555-020-09952-0
72
Anna J. Boland, Anthony A. O’Kane, Richard Buick, Daniel B. Longley, Christopher J. Scott. Antibody therapy in pancreatic cancer: mAb-ye we’re onto something?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(1): 188557 doi: 10.1016/j.bbcan.2021.188557
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345